Galecto (GLTO) Competitors

Equillium (NASDAQ:EQ) and Galecto (NASDAQ:GLTO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Which has stronger valuation and earnings, EQ or GLTO?

Equillium has higher revenue and earnings than Galecto. Equillium is trading at a lower price-to-earnings ratio than Galecto, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Equillium	$16.55M	4.10	-$8.07M	-$0.56	-3.39
Galecto	N/A	N/A	-$21.44M	-$13.13	-0.25

Does the media prefer EQ or GLTO?

In the previous week, Equillium had 1 more articles in the media than Galecto. MarketBeat recorded 2 mentions for Equillium and 1 mentions for Galecto. Galecto's average media sentiment score of 0.75 beat Equillium's score of -0.13 indicating that Galecto is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Equillium	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Galecto	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, EQ or GLTO?

Equillium has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Comparatively, Galecto has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500.

Is EQ or GLTO more profitable?

Galecto has a net margin of 0.00% compared to Equillium's net margin of -19.62%. Galecto's return on equity of -115.70% beat Equillium's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Equillium	-19.62%	-139.56%	-90.56%
Galecto	N/A	-115.70%	-95.42%

Do insiders & institutionals hold more shares of EQ or GLTO?

27.0% of Equillium shares are owned by institutional investors. Comparatively, 14.2% of Galecto shares are owned by institutional investors. 31.6% of Equillium shares are owned by company insiders. Comparatively, 10.8% of Galecto shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Do analysts recommend EQ or GLTO?

Equillium currently has a consensus target price of $1.00, suggesting a potential downside of 47.37%. Galecto has a consensus target price of $10.00, suggesting a potential upside of 199.40%. Given Galecto's stronger consensus rating and higher probable upside, analysts clearly believe Galecto is more favorable than Equillium.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Equillium	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Galecto	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Galecto beats Equillium on 8 of the 15 factors compared between the two stocks.